A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.

Also called NCT02080871

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 134 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02080871
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, New Zealand (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02080871. Allocation not applicable; no masking; primary purpose treatment. Start 2014-07 (actual); primary completion 2016-05 (actual). Results posted on 2018-07-17.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Acronym
VBXFLEX
Condition
Peripheral Arterial Disease
Intervention (Device)
Stenting of the Common and/or External Iliac Arteries
Lead sponsor
W.L.Gore & Associates (class: industry)

Record details

Record id
cardio:ct-nct02080871
Content hash
60c543cc47334bd3d79af68bd803f87e15314158490a4f67ee8d7a416a041bb2